Need professional-grade analysis? Visit stockanalysis.com
$7.81B
49.79
N/A
1.67%
Grifols SA (GRF-P) trades on Bolsa de Madrid in EUR. The company is classified in the Other sector under the Other industry. The stock currently trades at EUR6.65, up 0.45% from the previous close.
Over the past year, GRF-P has traded between a low of EUR5.56 and a high of EUR9.57. The stock has lost 1.9% over this period. It is currently 30.5% below its 52-week high.
Grifols SA has a market capitalization of $7.81B, with a price-to-earnings ratio of 49.79 and a dividend yield of 1.67%.
Grifols SA is a global healthcare company that specializes in the development, manufacture, and distribution of plasma-derived products, such as immunoglobulins, albumin, and clotting factors. The company's primary business involves the collection, processing, and fractionation of human plasma, which is used to produce a wide range of essential medical treatments for patients with various medical conditions, including immunodeficiencies, coagulation disorders, and neurological diseases.